6.27
-0.91 (-12.67%)
| 前收盘价格 | 7.18 |
| 收盘价格 | 6.64 |
| 成交量 | 1,145,941 |
| 平均成交量 (3个月) | 1,154,562 |
| 市值 | 321,483,808 |
| 预期市盈率 (P/E Forward) | 22.99 |
| 价格/销量 (P/S) | 0.490 |
| 股市价格/股市净资产 (P/B) | 1.00 |
| 52周波幅 | |
| 利润日期 | 2 Nov 2026 |
| 营业毛利率 | -13.63% |
| 营业利益率 (TTM) | 22.68% |
| 稀释每股收益 (EPS TTM) | -2.58 |
| 季度收入增长率 (YOY) | -26.00% |
| 季度盈利增长率 (YOY) | 655.60% |
| 总债务/股东权益 (D/E MRQ) | 121.71% |
| 流动比率 (MRQ) | 6.32 |
| 营业现金流 (OCF TTM) | 110.10 M |
| 杠杆自由现金流 (LFCF TTM) | 91.12 M |
| 资产报酬率 (ROA TTM) | -1.61% |
| 股东权益报酬率 (ROE TTM) | -21.63% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - Specialty & Generic (US) | 混合的 | 混合的 |
| Drug Manufacturers - Specialty & Generic (全球的) | 混合的 | 混合的 | |
| 股票 | Emergent BioSolutions Inc. | 混合的 | 看跌 |
AIStockmoo 评分
| 分析师共识 | NA |
| 内部交易活动 | -1.5 |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 相对估值 | 5.0 |
| 财务健康 | NA |
| AI Insight | NA |
| 平均 | 0.78 |
|
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - Specialty & Generic |
| 投资方式 | Small Value |
| 内部持股比例 | 2.83% |
| 机构持股比例 | 67.20% |
该时间范围内无数据。
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| DEGOLYER DONALD W | - | 7.07 | -17,800 | -125,846 |
| 累积净数量 | -17,800 | |||
| 累积净值 ($) | -125,846 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 7.07 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| DEGOLYER DONALD W | 董事 | 07 Oct 2026 | 自动卖出 (-) | 17,800 | 7.07 | 125,846 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合